On Monday, Blueberries Medical Corp. (CSE:BBM) (OTC:BBRRF) (FRA:1OA), the Canadian parent of Blueberries S.A.S., a Latin American licensed producer of naturally grown premium quality cannabis operating from central Colombia, reported its financial results for the quarter ended on March 31, 2022.
“Blueberries Medical Corp’s short-term strategy will be to minimize fixed structure costs and expenses, reducing capital and operational expenditures while preserving working capital to optimize the resource and cost structure and focus 100% on revenue-generating activities,” Guillermo Rodriguez, CFO of the company stated in a press release. “The company has begun to expand its commercial revenues, adding more services. We have started to provide extraction services to other Cannabis companies in Colombia and [the rest of] Latin America.”
